Business
Pfizer ends COVID-19 vaccine trial with 95 per cent efficacy – Sydney Morning Herald
Effectiveness of the vaccine was consistent across age and ethnicity demographics, and that there were no major side effects, a sign that the immunisation could…
The better-than-expected data from the two vaccines, both developed with new technology known as messenger RNA (mRNA), have raised hopes for an end to a resurgent pandemic that has killed more than 1.3 million people globally and wreaked havoc upon economies and daily life.
However, while some groups such as healthcare workers will be prioritised in the United States for vaccinations this year, it will be months before large-scale rollouts begin.
Pfizer said on Wednesday there had been 170 cases…
-
Noosa News19 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General17 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
Noosa News21 hours agoWomen’s Softball World Cup 2027 Redcliffe Brisbane
-
General21 hours agoMan dies at shopping centre car park at Charlestown following reports of assault